Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

Author： Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.9, 2012-09, pp. : 1193-1197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab Plus Irinotecan–Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

By Yildiz Ramazan   Buyukberber Suleyman   Uner Aytug   Yamac Deniz   Coskun Ugur   Kaya Ali Osman   Ozturk Banu   Yaman Emel   Benekli Mustafa  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 33-37

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients

By Saito Seiya   Hayashi Naoko   Sato Nobutaka   Iwatsuki Masaaki   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Watanabe Masayuki   Yoshida Minoru   Sakai Kenji   Katsumori Takashi   Katahuchi Shigeru   Shigaki Nobuyuki   Yamada Kazutaka   Kimura Masami   Tanigawa Tomio   Takano Sadamu   Kuramoto Masafumi   Baba Hideo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 689-695

Springer Publishing Company

Access to resources Recommend Favorite

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype

By            

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 17-26

Spandidos Publications

Access to resources Recommend Favorite

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By Rocha Lima Caio M.   Bayraktar Soley   Flores Aurea M.   MacIntyre Jessica   Montero Alberto   Baranda Joaquina C.   Wallmark John   Portera Chia   Raja Rajiv   Stern Howard   Royer-Joo Stephanie   Amler Lukas C.  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 727-731

Informa Healthcare

Access to resources Recommend Favorite

Clinical Predictors of Severe Toxicity in Patients Treated with Combination Chemotherapy with Irinotecan and/or Oxaliplatin for Metastatic Colorectal Cancer: A Single Center Experience

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 347-358

Humana Press, Inc

Access to resources Recommend Favorite